Sentien Biotech
Biju Parekkadan is an Assistant Professor of Bioengineering at Harvard Medical School. Prior to this, they were an Associate Professor at Rutgers University from 2017 to present. Biju also co-founded Sentien Biotechnologies, Inc. in 2008.
Biju Parekkadan received a Bachelor of Science (B.S.) in Biomedical Engineering from Rutgers University from 1999 to 2003. Biju then went on to receive a Doctor of Philosophy (Ph.D.) in Chemical and Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology from 2003 to 2008.
This person is not in any teams
Sentien Biotech
Sentien Biotechnologies, Inc. is a privately owned, clinical-stage company developing novel approaches to cell therapy. Sentien’s mission is to harness the power of cell therapy with innovative drug delivery systems to treat a wide range of acute inflammatory diseases.